Teladoc Health, Inc. reported an insider ownership change by Kelly Bliss involving the company’s common stock on July 6, 2026. The Form 4 disclosure describes a transaction covering 2,500 shares at a price of $9.50 per share, implying a transaction value of approximately $23,750. The filing notes that the transaction was carried out under a Rule 10b5-1 trading plan adopted by Bliss on August 14, 2025. Such plans allow insiders to arrange trades in advance under preset instructions, helping address concerns about trading while in possession of material nonpublic information. The provided filing text does not include the full transaction table, so it does not identify the transaction code, whether the shares were acquired or disposed of, or Bliss’s beneficial ownership after the transaction. Those details are typically included in the tabular portion of a Form 4, but they are not present in the supplied excerpt. The filing was signed on Bliss’s behalf by Adam C. Vandervoort as attorney-in-fact. The key reported action is therefore an insider common-stock transaction by Kelly Bliss on July 6, 2026, involving 2,500 Teladoc Health shares at $9.50 per share pursuant to a prearranged 10b5-1 plan.